OmniMSC-AMI

· Taiwan Bio Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OmniMSC-AMI, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients [Phase 1]

See pricing